"Evidence That Tamoxifen Preserves Bone Density in Late Post-menopausal Women With Breast Cancer."

According to the authors' abstract of an article published in Acta Oncologica, "Tamoxifen, which is used for treating breast cancer, exhibits estrogenic and antiestrogenic characteristics, depending on the tissue. In the human breast it acts as an antiestrogen, whereas estrogenic effects have been reported on endometrium and bone. The purpose of this study was to determine whether tamoxifen (TAM) prevents bone loss in elderly, post-menopausal women. Bone mineral density of the lumbar spine (SBD) was measured in elderly women (at least 10 years after menopause) 5 years after stage I or II breast cancer (n=111). The results showed that SBD in untreated patients (n=74) was significantly...

Want to see the full article?

• Purchase this article for only $3.00